🔹Prognostic model added more granularity to the existing IGCCCG risk classification 🔹Further re-analysis with addition of mediastinal NSGCTs in the full-paper soon #ASCO24 Amit Joshi Dr Akhil Kapoor gaganprakash Vedang Murthy Priyamvada Maitre Amandeep Arora

Our new issue is live! Looking forward to your comments and criticism. Sincere thanks to all authors, reviewers, editors and publishers for your contribution. Read here: bit.ly/3Kf29px #CRST #cancerawareness #cancertreatment #CancerResearch #MedTwitter #Oncology

Perhaps the first Triveoctin PET of India Tata Memorial Centre, Varanasi (MPMMCC & HBCH) Case of GBM IDH wild type Triveoctin targets αvβ8-Integrin which is a potent modulator of the immune system and an activator of transforming growth factor β (TGFβ). Its increased expression is seen in gliomas

World Hepatitis Day today!!! 🔅A lot of cases go unnoticed and culminate into cirrhosis and/or Cancer 🌞Public awareness remains the key Thanks to Gastroenterology Dept, IMS, BHU for inviting me for the talk on "Myths and Facts: HCC" Tata Memorial Centre, Varanasi (MPMMCC & HBCH) Anant Ramaswamy Dr Amol Akhade

Does adding Docetaxel in advanced gastric cancers help? academic.oup.com/jncics/article… important question in the management of gastric cancers answered in our scenario + genomic data bhawna sirohi Dr (Prof). Vijay Patil Dr Amol Akhade South Asian Journal Of Cancer ISMPO Shailesh V. Shrikhande Vanita Noronha, MBBS MD DM

Prof. Sanjay Popat giving an excellent talk on New Frontiers know lung cancer at Asian Pacific Oncology Summit, Kuala Lumpur. 🔑ADCs & KRAS inhibitors 🫁 New IOs 🔅Stimulating and thought provoking for young researchers. ASCO ESMO - Eur. Oncology Vanita Noronha, MBBS MD DM Tata Memorial Hospital Tata Memorial Centre, Varanasi (MPMMCC & HBCH)

Thanks Sir. Points highlighted: 🌄Collaboration is the key for growth of young researchers. 🏞Role of mentor is extremely important. 🏅Brighter future expected in Thoracic Oncology. Sanjay Popat Justin Gainor

#WCLC2024 Important aspect of Cancer treatment, often missed. ✨️EXERCISE IN ONCOLOGY: Take EXERCISE as Seriously as Medicine 🌏Very well covered by Prof. Nicole Culos Reed(Canada) 🎖At Joint session of ASCO & IASLC Ravi Prakash Lung Connect India The ASCO Post IASLC

Got Young Investigator Award at #WCLC for project aimed to provide insights into the Microbiome of Indian Lung Cancer patients receiving IO. Thanks to my mentors Kumar Sir, Vanita Noronha, MBBS MD DM Maam and B. K. Mishra Sir. Tata Memorial Centre, Varanasi (MPMMCC & HBCH) Narjust Florez, MD, FASCO Bipinesh Sansar Anuj Gupta

Slowly we've started to know importance of Microbiome🦠 in Cancer: Excellent talk and discussion at #WCLC24 by Arielle Elkrief, MD FRCPC 🥗Gut Microbiome: Key determinant of response to IO 🐶Metagenomic sequencing is Gold standard; PCR can give faster results ASCO IASLC Vanita Noronha, MBBS MD DM

Real world utilisation of therapies in EGFR+ Lung Ca 🌏Great insights by Sewanti Limaye 🇮🇳🇺🇸 at #WCLC24 🏥Squamous Lung Cancer: Should be tested for EGFR: TMH study was one of the first studies 🎗Gef+ Chemo is the most popular regimen in view of cost constraints Vanita Noronha, MBBS MD DM

Cancer Therapeutic vaccines: Are they the future? ✨️Interesting studies and early signals of efficacy for lung cancer 🫁 🥇Crisp summary of all the available data presented at #WCLC24 by Charu Aggarwal, MD, MPH, FASCO 🎖Large study in combination with Pembro planned. IASLC Vanita Noronha, MBBS MD DM

CAR-T cell in Lung Cancer: Hope or Hype? 🏆Some early data of good results: Further results awaited 🎈Targets of CAR T include GPC3, DLL3, ROR1, CEA, even ALK and EGFR 🎖Nice summary by Ben Creelan, MD at #WCLC24 Dr (Prof). Vijay Patil Lung Connect India Ravi Prakash Vanita Noronha, MBBS MD DM

📌Best of WCLC24 🌐Discover the future of lung cancer care! From groundbreaking research to inspiring talks and innovative screenings, #WCLC24 has it all. Don't miss the highlights and breakthroughs from San Diego!🔬 IASLC Jarushka Naidoo Noemi Reguart Cristiane D Bergerot Vivek Subbiah, MD